Find News

Filter articles

Applied Filters

Showing 51 to 60 of 232 results

MSF challenges Gilead patent in China


Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China.

Sage Therapeutics and Shionogi partner to develop antidepressant


US-based biopharmaceutical company Sage Therapeutics and Japan-based pharmaceutical corporation Shionogi have entered into a strategic collaboration to develop an antidepressant drug.

India launches project to help consumers identify counterfeit drugs via text message


India’s Drug Technical Advisory Board, which advises the government, has reportedly approved a “track and trace” proposal that will allow Indian consumers to identify whether their medicine is genuine simply by sending a text message.

Celgene drops trademark claim against online pharmacies

India, US10-05-2018

Biopharmaceutical company Celgene has ditched its trademark quarrel with the owners of India-based online pharmacies importing generics into the US.

India’s Supreme Court refuses to stay Monsanto patent order


India’s Supreme Court has refused to stay an order which held that agricultural company Monsanto’s patent on genetically modified cotton seeds is invalid.

Chugai abandons patent claim against Nippon Kayaku


Japan-based Chugai Pharmaceuticals has announced it has withdrawn its patent infringement claim against generic anti-cancer business Nippon Kayaku.

Monsanto suffers patent loss in India


Agriculture company Monsanto suffered a loss in India yesterday when the High Court of Delhi concluded that the company’s patent on genetically modified cotton seeds is not valid.

Takeda makes waves with neurological collaboration

Japan, US23-02-2018

Japan-based Takeda Pharmaceuticals has entered into a global strategic collaboration with Wave Life Sciences.

UK agrees £500m of life sciences deals in China

China, UK21-02-2018

More than £500 million worth of life sciences and healthcare agreements were signed between the UK and China during the UK Prime Minister’s visit to China earlier this month.

Astellas Pharma expands portfolio by acquiring Universal Cells

Japan, US16-02-2018

Japan-based Astellas Pharma has acquired US-based Universal Cells in a move that will allow it to develop universal donor cell technology.

Showing 51 to 60 of 232 results